— Know what they know.
Not Investment Advice
XOMAP (NASDAQ) is a cross-listing of XOMAO (NASDAQ). Showing primary listing data.

XOMAO

XOMA Corporation
1W: -0.6% 1M: -0.2% 3M: -0.9% YTD: +0.2% 1Y: +6.7% 3Y: +35.0%
$25.33
-0.01 (-0.04%)
After Hours: $24.68 (-0.65, -2.57%)
NASDAQ · Healthcare · Biotechnology · $306.0M · Alpha Radar Neutral · Power 50
Last Earnings 2026-03-18
EPS
$0.34
▲ Beat +394.6%
Revenue
$22M
▲ Beat +94.6%
EPS Beat Streak: 4 quarters
Next Earnings 2026-03-30
EPS Estimate
$-0.06
Range: $-0.06 - $-0.05
Revenue Estimate
$13M
1 analysts

Estimate vs Actual

Earnings Surprise History

4/15
EPS Beats
2/15
Revenue Beats
27%
EPS Beat Rate
13%
Rev Beat Rate

Wall Street Forward Estimates

Quarterly
Annual

Estimate Revisions

Recent Revisions
DatePeriodFiscal DateEPS OldEPS NewChangeRev OldRev New
2026-03-20 quarter 2026-03-31 $-0.06 $0.04 ▲ 0.10 $12,802,500 $12,968,333
2026-03-20 quarter 2026-12-31 $0.53 $0.44 ▼ 0.09 $23,406,000 $20,604,000
2026-03-20 annual 2026-12-31 $0.77 $0.81 ▲ 0.04 $63,608,750 $63,707,000
2026-03-20 annual 2028-12-31 $1.68 $1.80 ▲ 0.12 $81,200,000 $81,450,000
2026-03-20 quarter 2026-09-30 $0.39 $0.34 ▼ 0.05 $20,605,000 $18,603,333
2026-03-20 annual 2030-12-31 $3.17 $3.06 ▼ 0.12 $125,350,000 $120,650,000
2026-03-20 quarter 2026-06-30 $0.07 $0.14 ▲ 0.07 $15,053,500 $14,735,667
2026-03-20 annual 2029-12-31 $2.44 $2.54 ▲ 0.10 $97,150,000 $97,450,000
2026-03-20 annual 2027-12-31 $0.59 $0.69 ▲ 0.09 $61,300,000 $60,950,000
2026-03-19 quarter 2025-03-31 $— $-0.24 ▼ 0.24 $7,065,000
2026-03-19 annual 2027-12-31 $0.97 $0.59 ▼ 0.38 $67,850,000 $61,300,000
2026-03-19 annual 2030-12-31 $— $3.17 ▲ 3.18 $125,350,000
2026-03-19 quarter 2026-03-31 $— $-0.06 ▼ 0.06 $12,802,500
2026-03-19 quarter 2026-12-31 $— $0.53 ▲ 0.53 $23,406,000
2026-03-19 quarter 2025-12-31 $— $-0.11 ▼ 0.11 $11,050,000
Earnings Call Transcripts
No transcripts available.

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms